PB1864: BRUIN CLL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR’S CHOICE OF IDELALISIB+RITUXIMAB OR BENDAMUSTINE+RITUXIMAB IN BTKI PRETREATED CLL/SLL (TRIAL IN PROGRESS)

Autor:	J. P. Sharman, W. Jurczak, C. C. Coombs, M. Hill, D. Wang, N. C. Ku, A. Guntur, S. Shahda, C. C. Leow, P. Ghia, A. R. Mato
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	Diseases of the blood and blood-forming organs RC633-647.5
Zdroj:	HemaSphere, Vol 6, Pp 1744-1745 (2022)
Druh dokumentu:	article
ISSN:	2572-9241
DOI:	10.1097/01.HS9.0000850308.96349.64
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/91444f121bbd4639bd2470bd70b535f8 Zobrazit plný text záznamu Plný text View record in DOAJ